AngioDynamics Inc

Visual Financials
Company Name: AngioDynamics Inc
Ticker Symbol: ANGO
CIK Number: 0001275187
WWW Address: http://www.angiodynamics.com
CEO: Mr. James C. Clemmer
No. of Employees: 1,250
Common Issue Type: CS
Business Description:AngioDynamics, Inc. provides medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease, and local oncology therapy options for treating cancer.

 
Industry Information: HEALTH SERVICES - Medical Instruments & Supplies [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 19.61 Unchanged 0.0 18.75 24.5  19.16 18.84 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 729.8 37.2 0.00 0.44 0.00 43.5 0.0 25.48 - 18.11
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close19.07$
PE Ratio - LTM43.5
Market Capitalisation729.8mil
Latest Shares Outstanding37.2mil
Earnings pS (EPS)0.44$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee300,686$
Effective Tax Rate0.0%
Float31.4mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin51.4%
EBITDA Margin9.8%
Pre-Tax Profit Margin0.0%
Assets Turnover48.7%
Return on Assets (ROA)2.3%
Return on Equity (ROE)3.1%
Return on Capital Invested (ROCI)3.7%
Current Ratio2.9
Leverage Ratio (Assets/Equity)1.3
Interest Cover3.4
Total Debt/Equity (Gearing Ratio)0.17
LT Debt/Total Capital14.0%
Working Capital pS2.98$
Cash pS0.00$
Book-Value pS14.89$
Tangible Book-Value pS1.37$
Cash Flow pS0.95$
Free Cash Flow pS0.87$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.29
Price/Tangible Book Ratio0.00
Price/Cash Flow20.4
Price/Free Cash Flow22.3
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.5182,089735,777
4 Weeks20.3218.4619.99-4.6177,1483,365,812
13 Weeks25.4818.4621.59-11.7249,40515,712,572
26 Weeks25.4818.1120.78-8.2218,88427,141,730
52 Weeks25.4818.1121.30-10.5221,02255,255,539
YTD25.4818.46--3.7217,54123,494,487
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
18.9819.1120.7121.1421.330.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.000.1-0.01
Income1.1
Dividend0.0
Capital Spending0.09NA0.16
R&D7.94NA7.37
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %53.658.22.8
Earnings %-86.80.0-100.0
EPS %-87.50.0-100.0
EPS $-0.070.04-0.52
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio15.70
Current Ratio2.9
Quick Ratio (Acid Test)2.0
Liquidity Ratio (Cash)2.61
Receivables Turnover8.2
Average Collection Period44
Working Capital/Equity20.4
Working Capital pS3.00
Cash-Flow pS1.10
Free Cash-Flow pS1.00
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.77
Financial Leverage Ratio (Assets/Equity)0.2
Debt Ratio13.0
Total Debt/Equity (Gearing Ratio)0.17
LT Debt/Equity0.16
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities94.5
Interest Cover3.4
Interest/Capital Invested0.56
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.02
Current P/E Ratio - LTM43.50
Enterprise Value (EV)/EBITDA16.85
Enterprise Value (EV)/Free Cash Flow24.23
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.29
Price/Cash Flow Ratio20.4
Price/Free Cash Flow Ratio - LTM22.3
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM49.1
5-Y High P/E Ratio212.3
5-Y Low P/E Ratio80.9
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E10
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM73.4
PER SHARE FIGURES
LT Debt pS2.69
Current Liabilities pS1.78
Tangible Book Value pS - LTM1.37
Book Value pS - LTM14.89
Capital Invested pS17.04
Cash pS - LTM0.00
Cash Flow pS - LTM0.95
Free Cash Flow pS - LTM0.87
Earnings pS (EPS)0.44
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin10.93
Free Cash Flow Margin 5YEAR AVG8.85
Net Profit Margin0.1
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity0.63
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.54
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.50
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin51.4
Gross Profit Margin - 5YEAR AVRG.0.5
EBITDA Margin - LTM9.8
EBIT Margin - LTM3.1
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate0.5
Effective Tax Rate - 5YEAR AVRG.0.7
EFFICIENCY RATIOS
Cash Conversion Cycle885,679
Revenue per Employee300,686
Net Income per Employee14,266
Average Collection Period885,679
Receivables Turnover8.2
Day's Inventory Turnover Ratio
Inventory Turnover3.2
Inventory/Sales14.2
Accounts Payble/Sales4.58
Assets/Revenue2.00
Net Working Capital Turnover3.11
Fixed Assets Turnover0.64
Total Assets Turnover0.5
Revenue per $ Cash4.65
Revenue per $ Plant8.11
Revenue per $ Common Equity0.63
Revenue per $ Capital Invested0.54
Selling, General & Adm/tive (SG&A) as % of Revenue31.5
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue7.4
R&D Expense as % of Revenue - 5YEAR AVRG.7.4

  


Your Recent History
NASDAQ
ANGO
Angiodynam..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.